WallStreetZenWallStreetZen

NASDAQ: PIRS
Pieris Pharmaceuticals Inc Stock Ownership - Who owns Pieris Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Pieris Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Christopher P. KiritsyDirector2023-05-2510,000$0.85
$8.50kBuy

1 of 1

PIRS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PIRS insiders and whales buy or sell their stock.

PIRS Shareholders

What type of owners hold Pieris Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Inc20.83%20,609,863$3.24MInstitution
Lynx1 Capital Management LP9.88%9,775,849$1.53MInstitution
Aquilo Capital Management LLC3.72%3,675,530$577.06kInsider
Citadel Advisors LLC1.20%1,189,887$186.81kInstitution
Renaissance Technologies LLC1.08%1,065,007$167.21kInstitution
Blackrock Inc1.05%1,037,747$162.93kInstitution
Acadian Asset Management LLC0.97%962,358$151.09kInstitution
Vanguard Group Inc0.92%907,390$142.46kInstitution
Geode Capital Management LLC0.77%761,444$119.55kInstitution
Cm Management LLC0.76%750,000$117.75kInstitution

1 of 3

PIRS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PIRS38.94%4.72%Net Buying
COCP0.69%99.31%
EVAX1.18%0.00%
TRAW5.95%94.05%Net SellingNet Selling
PHGE14.70%48.14%Net Buying
View Top Biotech Stocks

Pieris Pharmaceuticals Stock Ownership FAQ

Who owns Pieris Pharmaceuticals?

Pieris Pharmaceuticals (NASDAQ: PIRS) is owned by 38.94% institutional shareholders, 4.72% Pieris Pharmaceuticals insiders, and 56.35% retail investors. Aquilo Capital Management LLC is the largest individual Pieris Pharmaceuticals shareholder, owning 3.68M shares representing 3.72% of the company. Aquilo Capital Management LLC's Pieris Pharmaceuticals shares are currently valued at $569.71k.

If you're new to stock investing, here's how to buy Pieris Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.